Evidence map›Paper›PMID 27256713›Full record

ReviewNature reviews. Rheumatology2016

The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions.

Shahla Abdollahi-Roodsaz, Steven B Abramson, Jose U Scher

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Rheumatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 142 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Double-side role of short chain fatty acids on host health via the gut-organ axes.Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2024
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Frontiers in microbiology · 2024
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shahla Abdollahi-RoodsazDepartment of Medicine, Division of Rheumatology, New York University School of Medicine and Hospital for Joint Diseases, 301 East 17th Street, Room 1608, New York, New York 10003, USA.
Steven B AbramsonDepartment of Medicine, Division of Rheumatology, New York University School of Medicine and Hospital for Joint Diseases, 301 East 17th Street, Room 1608, New York, New York 10003, USA.
Jose U ScherDepartment of Medicine, Division of Rheumatology, New York University School of Medicine and Hospital for Joint Diseases, 301 East 17th Street, Room 1608, New York, New York 10003, USA.
New York University Langone Orthopedic Hospital · US

Funding

Role of oral and intestinal microbiota in Rheumatoid ArthritisRC2AR058986 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ABRAMSON, STEVEN B, LITTMAN, DAN · 2009 to 2010
$4.0M
The Role of Gut and Skin Microbiome in Psoriatic ArthritisK23AR064318 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SCHER, JOSE U. · 2013 to 2016
$589k
Human Gut Microbiome as Modulator of Drug Response in Inflammatory ArthritisR03AR072182 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SCHER, JOSE U. · 2017 to 2018
$170k
NIAMS NIH HHS K23 AR064318NIAMS NIH HHS R03 AR072182NIAMS NIH HHS RC2 AR058986
6 · The paper itself

Abstract

The role of the gut microbiome in animal models of inflammatory and autoimmune disease is now well established. The human gut microbiome is currently being studied as a potential modulator of the immune response in rheumatic disorders. However, the vastness and complexity of this host-microorganism interaction is likely to go well beyond taxonomic, correlative observations. In fact, most advances in the field relate to the functional and metabolic capabilities of these microorganisms and their influence on mucosal immunity and systemic inflammation. An intricate relationship between the microbiome and the diet of the host is now fully recognized, with the microbiota having an important role in the degradation of polysaccharides into active metabolites. This Review summarizes the current knowledge on the metabolic role of the microbiota in health and rheumatic disease, including the advances in pharmacomicrobiomics and its potential use in diagnostics, therapeutics and personalized medicine.

Indexed as

Antirheumatic AgentsBile Acids and SaltsDietFatty Acids, VolatileFecal Microbiota TransplantationGastrointestinal MicrobiomeHumansPrebioticsProbioticsRheumatic DiseasesAntirheumatic AgentsBile Acids and SaltsFatty Acids, VolatilePrebiotics

Identifiers

PMID27256713
OpenAlexW2413213144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.